Header graphic for print
Dangerous Drugs & Medical Devices News & Commentary on Prescription Drug & Medical Device Lawsuits

FDA Cites Three Cases of Diabetes Associated with Abilify

Posted in Uncategorized

Between 2008 and 2009, a number of adverse events were reported to the FDA regarding second-generation (atypical) antipsychotic drugs Seroquel (quetiapine fumarate), Risperdal (risperidone), Zyprexa (olanzapine), Geodon (ziprasidone), and Abilify (aripiprazole) among children aged 6-17.

Click here to read the full FDA Adverse Event Report on Atypical Antipsychotics among children (2008-2009).

The report states that adverse events most commonly included “Type I/II diabetes, weight gain, and high cholesterol/triglycerides”, and stresses that not all adverse events experienced are reported to the FDA, so the rate of certain adverse events cannot be determined from Adverse Event Reports.

Here is a summary of adverse events detailed in the FDA report:

abilify-lawyer-abilify-lawsuit-abilify-diabetes-lawsuit

Concerning Abilify, the cases of diabetes are as follows.  First, a 12-year-old girl who used Abilify for bipolar disorder developed type-II diabetes and gained 150 pounds in one year alone, reporting blood glucose of 195-305.  A 17-year-old male who was also using Abilify for bipolar disorder “developed diabetes” and experienced weight gain of 14-40 pounds.  Lastly, a 14-year old male using Abilify presented with “Polydipsia, polyuria, diabetes mellitus, fatigue, hyperglycaemia, ketoacidosis, pollakiuria, urine abnormality, vision blurred, ketonuria, type 1 diabetes mellitus, [and] weight decreased”.

Due to the fact that the manufacturers of second generation antipsychotics such as Abilify and others have failed to adequately warn users of the risk for diabetes associated with their products, a number of Abilify diabetes lawsuits and antipsychotic diabetes lawsuits have been filed.

If you or a loved one used Abilify or another antipsychotic and developed diabetes as a result, you too may be entitled to significant financial compensation from the manufacturer.  For a free, no-obligation case consultation, contact our team of Abilify diabetes lawyers at the information provided below.  We have the experience, resources, and skills required to win the justice you deserve.

Call today and see how we can help.

(855) 452 – 5529

justinian@dangerousdrugs.us